Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Ocul Pharmacol Ther ; 28(2): 102-9, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22060001

ABSTRACT

PURPOSE: To evaluate the performance of 6-O-Lauryl-l-ascorbic acid nanostructures (coagels) as vehicles for acetazolamide (AZM) in ophthalmic administration by in vitro and in vivo experimental tests. METHODS: The systems of coagel + AZM were evaluated in terms of their in vitro release (dialysis membrane), permeability (isolated cornea), pharmacological effectiveness [intraocular pressure (IOP)-reduction in normotensive rabbits], and potential irritant effects. RESULTS: The results concerning AZM permeation were better when vehiculized in coagels compared with ringer solution, which was evident from the AZM steady-state flux and P(app) values (J=1.43 µg/min and P(app)=3.04 cm.s(1)). As a consequence of this increase in permeation, the coagel-AZMs were more effective in lowering the IOP, according to the results obtained from the in vivo assays. Coagels loaded with 0.4% (W/W) of AZM showed a higher hypotensive effect in rabbits compared with the commercial formulation AZOPT(®) (brinzolamide 1%), mainly due to the prolonged effect of the former. In all cases, the intensity of irritation was time dependent. The sodium lauryl sulphate solution (2%) used as a positive control produced serious injury 30 min postadministration. This effect caused irritation, which decreased slowly and even at 180 min, the discomfort was still considerable. However, in the case of coagels, a mild-to-moderate effect was observed. CONCLUSIONS: The incorporation of AZM in coagels seems to improve the ocular bioavailability of this drug. Coagel-AZM 0.4% showed a higher hypotensive effect, with a mild-to-moderate irritant effect. These systems could be administrated in human beings, although more detailed studies still need to be carried out.


Subject(s)
Acetazolamide/administration & dosage , Acetazolamide/pharmacokinetics , Ascorbic Acid/analogs & derivatives , Carbonic Anhydrase Inhibitors/administration & dosage , Carbonic Anhydrase Inhibitors/pharmacokinetics , Cornea/metabolism , Drug Carriers/chemistry , Nanostructures/chemistry , Acetazolamide/pharmacology , Acetazolamide/toxicity , Animals , Ascorbic Acid/chemistry , Biological Availability , Carbonic Anhydrase Inhibitors/pharmacology , Carbonic Anhydrase Inhibitors/toxicity , Dialysis , Drug Delivery Systems , Intraocular Pressure/drug effects , Ophthalmic Solutions , Permeability , Rabbits
2.
AAPS PharmSciTech ; 12(2): 514-20, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21491181

ABSTRACT

Ferulic acid (FA) is a natural product that occurs in seeds of many plants where it is generally located in the bran. This compound is a multifunctional ingredient endowed with antioxidative, radical scavenging, sunscreening and antibacterial actions. The aim of this study was to analyse the ferulic acid cutaneous permeation and distribution, through and into the skin layers, from different cosmetic vehicles, an O/W emulsion (pH 6.0) and two gel-type formulations at different pH levels (6.0 and 7.4), containing FA alone or an inclusion complex with α-cyclodextrin (CD-FA). In vitro permeation studies were performed in vertical diffusion cells using hairless rat excised skin. At appropriate intervals of time, the amount of permeated sunscreen/radical scavenger was evaluated by high-performance liquid chromatography (HPLC). At the end of experiments, treated skin samples were sectioned with a cryomicrotome and the FA content of the individual slices was analysed by HPLC. FA-containing formulations, O/W emulsion, gels A and B, originated FA fluxes of 8.48 ± 2.31, 8.38 ± 0.89 and 5.72 ± 0.50 µg/cm(2) h, respectively, thus suggesting the pH influence on FA percutaneous permeation. The use of the inclusion complex, CD-FA, determined in all cases a decrease of FA transdermal permeation while no influence of pH was observed. Gel-type formulations containing FA ensured higher sunscreen storage in the superficial layers if compared with O/W emulsion. When FA was included in α-cyclodextrin, FA amount retained into skin layers decreased markedly.


Subject(s)
Coumaric Acids/pharmacokinetics , Skin Absorption/physiology , alpha-Cyclodextrins/pharmacokinetics , Administration, Topical , Animals , Chemistry, Pharmaceutical/standards , Coumaric Acids/administration & dosage , Coumaric Acids/standards , Male , Permeability , Rats , Rats, Hairless , Skin Absorption/drug effects , alpha-Cyclodextrins/administration & dosage , alpha-Cyclodextrins/standards
SELECTION OF CITATIONS
SEARCH DETAIL
...